drugset / Trial / NCT07199309

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

NCT07199309 ↗

Phase 2 Recruiting 30 enrolled Marea Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.

Timeline

Start
2025-09-26
Primary completion
2026-07
Completion
2026-11

Drugs

EvaluationDrugModalityDoseRoute
Subject MAR001 Unknown — Subcutaneous

Indications